These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36441658)

  • 21. Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjögren's syndrome.
    Sariyildiz A; Coskun Benlidayi I; Yetişir A; Turk I; Zengin Acemoglu SS; Deniz V
    Clin Rheumatol; 2024 Jun; 43(6):1949-1958. PubMed ID: 38691249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.
    Baer AN; Gottenberg JE; St Clair EW; Sumida T; Takeuchi T; Seror R; Foulks G; Nys M; Mukherjee S; Wong R; Ray N; Bootsma H
    Ann Rheum Dis; 2021 Mar; 80(3):339-348. PubMed ID: 33168545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cutaneous silent period parameters in patients with primary Sjögren's syndrome with the healthy population and determination of ıts relationship with clinical parameters.
    Yolcu G; Abacar KY; Kenis-Coskun O; Nevsun-Inanc G; Karadag-Saygi E; Gunduz OH
    Rheumatol Int; 2023 Feb; 43(2):355-362. PubMed ID: 36048188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
    Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF;
    Rheumatology (Oxford); 2015 Apr; 54(4):655-9. PubMed ID: 25240612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EULAR Sjögren's Syndrome Patient-Reported Index is an independent determinant of health-related utility values of Korean patients with primary Sjögren's syndrome.
    Lee J; Koh JH; Kwok SK; Park SH
    Clin Exp Rheumatol; 2016; 34(4):663-7. PubMed ID: 27050672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life.
    Tarn J; Lendrem D; McMeekin P; Lendrem C; Hargreaves B; Ng WF
    J Intern Med; 2022 Jun; 291(6):849-855. PubMed ID: 35018685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.
    Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
    Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
    Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
    Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
    Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
    Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
    Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.
    Dumusc A; Ng WF; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S
    Swiss Med Wkly; 2018; 148():w14588. PubMed ID: 29442344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain, xerostomia, and younger age are major determinants of fatigue in Korean patients with primary Sjögren's syndrome: a cohort study.
    Koh JH; Kwok SK; Lee J; Son CN; Kim JM; Kim HO; Park SH; Sung YK; Choe JY; Lee SS; Park SH
    Scand J Rheumatol; 2017 Jan; 46(1):49-55. PubMed ID: 27098775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abdominal symptoms during Sjogren's syndrome: a pilot study.
    Parreau S; Jacques J; Dumonteil S; Palat S; Geyl S; Gondran G; Bezanahary H; Liozon E; Azaïs J; Colombie S; Jauberteau MO; Loustaud-Ratti V; Ly KH; Fauchais AL
    Adv Rheumatol; 2021 Jan; 61(1):5. PubMed ID: 33468262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients.
    Jiang W; Zhang L; Zhao Y; He X; Hu C; Liu Y
    Int Ophthalmol; 2020 Nov; 40(11):3059-3065. PubMed ID: 32607949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain and fatigue are predictors of quality of life in primary Sjögren's syndrome.
    Dias LH; Miyamoto ST; Giovelli RA; de Magalhães CIM; Valim V
    Adv Rheumatol; 2021 May; 61(1):28. PubMed ID: 34051867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of the efficacy and safety of herbal decoction CheReCunJin alone and combined with hydroxychloroquine for treating primary Sjögren's syndrome: A randomized controlled trial.
    Shao Q; Jin L; Li C; Wang J; Wang M; Wang Q; Wu B
    Explore (NY); 2022; 18(4):416-422. PubMed ID: 34417112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatigue in Saudi Patients with Primary Sjögren's Syndrome and Its Correlation with Disease Characteristics and Outcome Measures: A Cross-Sectional Study.
    AlEnzi F; Alqahtani B; Alhamad EH; Daghestani M; Tashkandy Y; Othman N; Alshahrani K; Paramasivam MP; Halwani R; Omair MA
    Open Access Rheumatol; 2020; 12():303-308. PubMed ID: 33293878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic.
    Pertovaara M; Korpela M
    Rheumatology (Oxford); 2014 May; 53(5):927-31. PubMed ID: 24464708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL.
    Lackner A; Stradner MH; Hermann J; Unger J; Stamm T; Graninger WB; Dejaco C
    Semin Arthritis Rheum; 2018 Aug; 48(1):105-110. PubMed ID: 29395257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.